Karin Eklund Vanderpol
Geen lopende functies
Profiel
Karin Eklund Vanderpol formerly worked at Swedish Orphan Biovitrum AB, as Director-Global Regulatory Affairs, AstraZeneca AB, as Head-Regulatory Affairs, and Oncopeptides AB, as Head-Regulatory Affairs from 2020 to 2022.
Ms. Vanderpol received her graduate degree from the University of Uppsala.
Eerdere bekende functies van Karin Eklund Vanderpol
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOPEPTIDES AB | Algemeen Adviseur | 01-01-2022 |
| SWEDISH ORPHAN BIOVITRUM AB | Algemeen Adviseur | 01-12-2019 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Algemeen Adviseur | - |
Opleiding van Karin Eklund Vanderpol
| University of Uppsala | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ONCOPEPTIDES AB | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
